We are live on ! Find out more
RP

Rowlandmiller & Partners Portfolio holdings

AUM $549M
1-Year Est. Return 36.2%
This Fund
S&P 500
This Quarter Est. Return
+1.63%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$459M
AUM Growth
-$15.1M
Cap. Flow
-$16M
Cap. Flow %
-3.5%
Top 10 Hldgs %
38.72%
Holding
186
New
5
Increased
32
Reduced
83
Closed
9

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.38M
2
AAPL icon
Apple
AAPL
+$1.27M
3
QCOM icon
Qualcomm
QCOM
+$1.21M
4
PGR icon
Progressive
PGR
+$1.15M
5
ADP icon
Automatic Data Processing
ADP
+$853K

Sector Composition

Rank Sector Weight
1 Technology 24.11%
2 Financials 15%
3 Healthcare 13.84%
4 Industrials 11.15%
5 Consumer Staples 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
151
Thermo Fisher Scientific
TMO
$213B
$129K 0.03%
234
DFAC icon
152
Dimensional US Core Equity 2 ETF
DFAC
$47.9B
$125K 0.03%
3,879
UNH icon
153
UnitedHealth
UNH
$376B
$125K 0.03%
245
REGN icon
154
Regeneron Pharmaceuticals
REGN
$78.5B
$122K 0.03%
116
AVNT icon
155
Avient
AVNT
$3.33B
$120K 0.03%
2,745
-100
-4% -$4.38K
MA icon
156
Mastercard
MA
$502B
$119K 0.03%
270
VOO icon
157
Vanguard S&P 500 ETF
VOO
$979B
$118K 0.03%
235
-21
-8% -$10.1K
NOBL icon
158
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
$117K 0.03%
2,436
+40
+2% +$1.96K
T icon
159
AT&T
T
$159B
$114K 0.02%
+5,965
New +$104K
ROP icon
160
Roper Technologies
ROP
$38.8B
$114K 0.02%
202
RY icon
161
Royal Bank of Canada
RY
$291B
$111K 0.02%
1,042
CCEL icon
162
Cryo-Cell International
CCEL
$27.6M
$110K 0.02%
14,433
SMG icon
163
ScottsMiracle-Gro
SMG
$3.82B
$109K 0.02%
1,683
-150
-8% -$10.3K
TSCO icon
164
Tractor Supply
TSCO
$16.1B
$109K 0.02%
2,025
-900
-31% -$48.4K
MLM icon
165
Martin Marietta Materials
MLM
$31.5B
$108K 0.02%
200
CSCO icon
166
Cisco
CSCO
$457B
$108K 0.02%
2,279
PANW icon
167
Palo Alto Networks
PANW
$270B
$102K 0.02%
+600
New +$89.7K
DTE icon
168
DTE Energy
DTE
$29.5B
$101K 0.02%
912
-294
-24% -$32.9K
GEHC icon
169
GE HealthCare
GEHC
$30.7B
$101K 0.02%
1,295
BNY
170
Bank of New York Mellon
BNY
$106B
$100K 0.02%
+1,678
New +$97.1K
BIIB icon
171
Biogen
BIIB
$30B
-479
Closed -$103K
CLX icon
172
Clorox
CLX
$11.6B
-716
Closed -$110K
CMP icon
173
Compass Minerals
CMP
$1.23B
-18,980
Closed -$299K
GL icon
174
Globe Life
GL
$14.2B
-3,207
Closed -$373K
LOW icon
175
Lowe's Companies
LOW
$117B
-556
Closed -$142K

Similar funds

Rowlandmiller & Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Rowlandmiller & Partners held 186 positions worth $459M, down 3.2% from $474M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Rowlandmiller & Partners withdrew a net $16M in Q2 2024, closing 9 positions and reducing 83 holdings. Its most notable exit was Globe Life, an estimated $373K position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Rowlandmiller & Partners opened a new position in lululemon athletica worth $1.2M.

  • Rowlandmiller & Partners's largest Q2 2024 buy was lululemon athletica: 4,009 shares worth $1.2M.
  • Rowlandmiller & Partners added most to Medtronic in Q2 2024, an estimated $566K increase.
  • Rowlandmiller & Partners's biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $1.38M.
  • Rowlandmiller & Partners fully exited Globe Life in Q2 2024, selling an estimated $373K.
  • Rowlandmiller & Partners's ten largest holdings make up 39% of its $459M portfolio in Q2 2024.
  • Rowlandmiller & Partners opened 5 new positions and closed 9 in Q2 2024.
  • Rowlandmiller & Partners's portfolio value fell 3.2% quarter-over-quarter to $459M.

Based on Rowlandmiller & Partners's 13F filing for Q2 2024, filed 29 Jul 2024.